Scientists have uncovered a key step in the wound healing process that becomes disabled in diseases like diabetes and aging, contributing to a global healthcare cost of managing poorly healing wounds exceeding $250 billion a year. Importantly, the research reveals a molecule involved in the healing of tissues that — when injected into animal models — leads to a drastic acceleration of wound closure, up to 2.5 times faster, and 1.6 times more muscle regeneration.